Paroxysmal nocturnal hemoglobinuria – first treatment experience with eculizumab in Slovenian patients
Background: Paroxysmal nocturnal hemoglobinuria is a serious form of acquired haemolytic anaemia characterized by a defect in the membrane of red blood cells and also platelets and neutrophils. Clinically, it is typified by the classical triad of (1) intravascular haemolysis, (2) venous thrombosis a...
Main Author: | Irena Preložnik Zupan |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2012-12-01
|
Series: | Zdravniški Vestnik |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/746 |
Similar Items
-
The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
by: Richard Kelly, et al.
Published: (2009-11-01) -
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA - RECOMMENDATIONS FOR DIAGNOSIS AND EXAMINATION OF THE PATIENT POPULATION IN SLOVENIA
by: Jasmina Hauptman, et al.
Published: (2016-10-01) -
Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
by: Michael J. Fassett, et al.
Published: (2021-04-01) -
Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations
by: Al-Ani F, et al.
Published: (2016-08-01) -
Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation
by: Brodsky Andrés, et al.
Published: (2012-09-01)